ASweetLife Team, Author at ASweetLife

Biodel Obtains Technologies for Development of Glucagon Formulations

Biodel Inc. has partnered with Aegis Therapeutics, LLC (Aegis) and has obtained exclusive worldwide license to Aegis' proprietary ProTek and Intravail technologies for the development and commercialization of pharmaceutical formulations of glucagon...

Tandem to Begin Distributing t:slim Insulin Pump in August

Tandem announced today, at the 72nd Scientific Sessions of the American Diabetes Association, that it will begin accepting orders for the t:slimTM Insulin Delivery System, the first insulin pump approved by the FDA with a touch screen...

Medtronic Files For FDA Approval Of Minimed 530G System Featuring Threshold Suspend Automation

In the next step toward the development of an artificial pancreas, Medtronic announced that it has filed the final module of its Pre-Market Approval (PMA) application with the U.S. Food and Drug Administration for the MiniMed 530G system featuring Threshold Suspend Automation. If approved...

FDA Extends Review Period of Novo Nordisk’s Ultra-Long-Acting Insulins

The U.S. FDA has informed Novo Nordisk that a three-month extension period was required in order to complete its regulatory review of the new drug applications (NDA) for the ultra-long-acting insulins degludec and insulin degludec/insulin aspart...

Moroccan Carrot Salad

We're big fans of Casual Kitchen, a food blog focused on food philosophy, money-saving ideas and easy and inexpensive recipes. So we're very glad its author, Daniel Koontz...

Jentadueto, a Combination Therapy for Type 2 Diabetes Recommended for approval in the EU

The European Medicines Agency's (EMA) medicinal committee has recommended the approval of Jentadueto, a type 2 diabetes drug, from Boehringer Ingelheim and Eli Lilly. Jentadueto (linagliptin/metformin hydrochloride) tablets are a medicine combining the DPP-4 inhibitor, linagliptin...

The Diabetes Declarations Art Project

Artist Jen Jacobs, who has been living with type 1 diabetes since the age of 12, is launching a new diabetes art project. And the best part is that it involves you! Jen is reaching out to members of the diabetes community and asking us to e-mail a declaration to her.

DiaPep277 Granted Orphan Drug Designation by FDA

The U.S. FDA has granted Orphan Drug designation for DiaPep277 for the treatment of type 1 diabetes (T1D) patients with residual beta cell function. The designation of Orphan Drug status offers 7 years marketing exclusivity from the time of approval....

Tradjenta Proves Effective in African Americans with Type 2 Diabetes

Boehringer Ingelheim and Eli Lilly announced results of a Phase 3 study in African American adults that shows taking Tradjenta (linagliptin) 5mg once-daily tablets sgnificantly reduces hemoglobin A1c (HbA1c)...

Novo Nordisk’s Levemir Insulin Approved for Use in Children as Young as Two

The U.S. Food and Drug Administration (FDA) has approved Levemir (insulin detemir [rDNA origin] injection) for use in children ages two to five years with type 1 diabetes, making it the first and only basal insulin analog for use in this young patient group. With the expansion of its pediatric indication...